{"id":"https://openalex.org/W2604469807","doi":"https://doi.org/10.1016/s2213-8587(17)30092-x","title":"Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial","display_name":"Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial","alternate_titles":[],"publication_year":2017,"publication_date":"2017-04-03","ids":{"openalex":"https://openalex.org/W2604469807","doi":"https://doi.org/10.1016/s2213-8587(17)30092-x","mag":"2604469807","pmid":"https://pubmed.ncbi.nlm.nih.gov/28385659"},"language":"en","primary_location":{"id":"doi:10.1016/s2213-8587(17)30092-x","doi":"https://doi.org/10.1016/s2213-8587(17)30092-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2213-8587(17)30092-x","pdf_url":null,"source":{"id":"https://openalex.org/S2529869117","display_name":"The Lancet Diabetes & Endocrinology","issn_l":"2213-8587","issn":["2213-8587","2213-8595"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Diabetes &amp; Endocrinology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2604469807"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027109387","display_name":"Bo \u00c5hr\u00e9n","orcid":"https://orcid.org/0000-0002-9804-5340","observed_orcids":["https://orcid.org/0000-0002-9804-5340"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Bo Ahr\u00e9n","raw_affiliation_strings":["Department of Clinical Sciences, Division of Medicine, Lund University, Lund, Sweden. Electronic address: bo.ahren@med.lu.se","Department of Clinical Sciences, Division of Medicine, Lund University, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Sciences, Division of Medicine, Lund University, Lund, Sweden. Electronic address: bo.ahren@med.lu.se","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Department of Clinical Sciences, Division of Medicine, Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068027334","display_name":"Llu\u00eds Masmiquel","orcid":"https://orcid.org/0000-0002-6549-5652","observed_orcids":["https://orcid.org/0000-0002-6549-5652"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Masmiquel","raw_affiliation_strings":["Balearic Institute of Endocrinology and Nutrition (IBEN), Hospital Quir\u00f3nsalud Palmaplanas, Palma de Mallorca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Balearic Institute of Endocrinology and Nutrition (IBEN), Hospital Quir\u00f3nsalud Palmaplanas, Palma de Mallorca, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Harish Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I81556334","display_name":"Amrita Vishwa Vidyapeetham","ror":"https://ror.org/03am10p12","country_code":"IN","type":"education","lineage":["https://openalex.org/I81556334"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Harish Kumar","raw_affiliation_strings":["Amrita Viswa Vidyapeetham University, Kochi, Kerala, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amrita Viswa Vidyapeetham University, Kochi, Kerala, India","institution_ids":["https://openalex.org/I81556334"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076056212","display_name":"Mehmet Akif Sargin","orcid":"https://orcid.org/0000-0003-4793-6941","observed_orcids":["https://orcid.org/0000-0003-4793-6941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehmet Sargin","raw_affiliation_strings":["Kartal Training and Research Hospital, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kartal Training and Research Hospital, Istanbul, Turkey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008923622","display_name":"Julie Derving Karsb\u00f8l","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Julie Derving Karsb\u00f8l","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006879238","display_name":"Sanja Hald Jacobsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Sanja Hald Jacobsen","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110447350","display_name":"Francis C. C. Chow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Francis Chow","raw_affiliation_strings":["Chinese University of Hong Kong, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chinese University of Hong Kong, Hong Kong, China","institution_ids":["https://openalex.org/I177725633"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5027109387"],"corresponding_institution_ids":["https://openalex.org/I187531555"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":null,"fwci":26.4042,"has_fulltext":false,"cited_by_count":562,"citation_normalized_percentile":{"value":0.99811472,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"5","issue":"5","first_page":"341","last_page":"354"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.984000027179718},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8550000190734863},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7900000214576721},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7239999771118164},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9779999852180481},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.9160000085830688},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8529999852180481},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6840000152587891},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6039999723434448},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9913491010665894},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.971088171005249},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9216734170913696},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7923141121864319},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6599174737930298},{"id":"https://openalex.org/C2910260750","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin Phosphate","level":5,"score":0.651205837726593},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6229323148727417},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5175753831863403},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5061168074607849},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48533836007118225},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3496754467487335},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.34857064485549927},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3257218301296234},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2926350235939026},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2634672522544861},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.15060749650001526},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.10735687613487244},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s2213-8587(17)30092-x","doi":"https://doi.org/10.1016/s2213-8587(17)30092-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2213-8587(17)30092-x","pdf_url":null,"source":{"id":"https://openalex.org/S2529869117","display_name":"The Lancet Diabetes & Endocrinology","issn_l":"2213-8587","issn":["2213-8587","2213-8595"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Diabetes &amp; Endocrinology","raw_type":"journal-article"},{"id":"pmid:28385659","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28385659","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The lancet. Diabetes & endocrinology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:lup.lub.lu.se:7057de0e-bf69-46c3-8472-5f379e8ba1e9","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/7057de0e-bf69-46c3-8472-5f379e8ba1e9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 2213-8587","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W108299943","https://openalex.org/W1559082056","https://openalex.org/W1893948433","https://openalex.org/W1910083626","https://openalex.org/W1924318177","https://openalex.org/W1969335462","https://openalex.org/W2007221722","https://openalex.org/W2010033044","https://openalex.org/W2019513002","https://openalex.org/W2044293101","https://openalex.org/W2048981028","https://openalex.org/W2059158127","https://openalex.org/W2071835038","https://openalex.org/W2072691447","https://openalex.org/W2090054860","https://openalex.org/W2091480327","https://openalex.org/W2092955095","https://openalex.org/W2096048424","https://openalex.org/W2098083442","https://openalex.org/W2109416725","https://openalex.org/W2111876001","https://openalex.org/W2117764934","https://openalex.org/W2118805427","https://openalex.org/W2123946565","https://openalex.org/W2140666083","https://openalex.org/W2144605125","https://openalex.org/W2160088494","https://openalex.org/W2162140339","https://openalex.org/W2162523308","https://openalex.org/W2171294019","https://openalex.org/W2196942236","https://openalex.org/W2519510391","https://openalex.org/W2572398654","https://openalex.org/W2734450568","https://openalex.org/W3114072797","https://openalex.org/W4235291177","https://openalex.org/W4240794548","https://openalex.org/W6604396958"],"related_works":["https://openalex.org/W2525452711","https://openalex.org/W3093123473","https://openalex.org/W2602700371","https://openalex.org/W3185437491","https://openalex.org/W2572398654","https://openalex.org/W2974008202","https://openalex.org/W2922550132","https://openalex.org/W4385326105","https://openalex.org/W2918407168","https://openalex.org/W2743930068"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2604469807","counts_by_year":[{"year":2026,"cited_by_count":76},{"year":2025,"cited_by_count":86},{"year":2024,"cited_by_count":73},{"year":2023,"cited_by_count":56},{"year":2022,"cited_by_count":71},{"year":2021,"cited_by_count":47},{"year":2020,"cited_by_count":45},{"year":2019,"cited_by_count":40},{"year":2018,"cited_by_count":59},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2017-04-14T00:00:00"}
